EDUCATE YOUR CLIENTS
ON RISK OF DISEASE
AND PROTECTING THEIR
PETS
Canine Influenza Disease Posts
2019 Bay Area Outbreak
2019 Before Dog Flu Exposure
2019 Don’t Wait Vaccinate
2019 Greater Portland Area Outbreak
2019 Sacramento Area Outbreak
2019 Southern California Outbreak
Dog Flu Has Been Found in 46 States
Dog Flu Infection Rates Are High
Dog Flu is On the Rise
Sneezes Aren’t Cute
No items to show.
Lyme Disease Posts
Canine Diabetes Disease Posts
No items to show.
Feline Diabetes Disease Posts
Cat at Water Bowl
Cat Drinking Water
Cat Napping
January Week 4: Frequenting the Water Bowl
No items to show.
Leptospirosis Disease Posts
Lepto Lives in Mud
Leptospirosis: What Is It and How to Protect Your Pet
Puddles Harbor Germs
No items to show.
Canine Cough & Other Respiratory Disease Posts
Parvovirus Disease Posts
Heartworm Disease Posts
Canine Otitis Externa Posts
Social Media How-To Guide
A social media step-by-step guide to help you create and maintain your healthcare team’s social media channels, tap into the right audiences and see what content gets the best response.
Drive Your Business with the Right Message
Choose from any of the filters (Brand, Outbreak or Disease) and easily find content that educates clients about disease and outbreak risks, compelling them to protect their pets with the right Merck Animal Health products.
Activyl®
Innovative flea treatment that is highly effective at killing fleas and preventing infestation.
Adherence
Infographic
BRAVECTO®
Up to 12 weeks* of continuous protection against fleas and ticks for dogs and cats.
No items to show.
*Bravecto kills fleas and prevents flea infestations for 12 weeks. Bravecto Chew and Bravecto Topical for Dogs kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. Bravecto Topical for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks.
IMPORTANT SAFETY INFORMATION: Bravecto has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. Bravecto Chew: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. Bravecto Topical Solution for Dogs: The most common adverse reactions recorded in clinical trials were vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. Use caution in dogs with a history of seizures. Seizures have been reported in dogs receiving fluralaner, even in dogs without a history of seizures. Bravecto Topical Solution for Cats: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. Bravecto is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of Bravecto has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving Bravecto, even in cats without a history of neurologic abnormalities.